Bayer promises to behave itself with Viterion TeleHealthcare

OK, I’ve truncated the story a bit for the sake of a reasonably concise headline, so here’s the first paragraph of the press release:

“Bayer HealthCare LLC confirmed today that it has reached a settlement with the United States Department of Justice (DOJ) related to an investigation into the Diabetes Care division’s historical marketing programs with certain mail order customers that took place during the period between 1998 and 2003. Bayer has cooperated fully with the DOJ’s civil investigation that commenced in 2003, without acknowledging liability. Under the terms of the agreement, Bayer HealthCare LLC will pay US-Dollar 97.5 million to the government, and will enter into a Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) for the Department of Health and Human Services. The BHC divisions covered by the CIA are those that sell products to Federal government entities (such as the VA) and /or sell products for which claims are submitted for reimbursement under Federal healthcare programs: Bayer HealthCare Diabetes Care, Bayer HealthCare Pharmaceuticals, Medrad (including Possis), Intendis and Viterion TeleHealthcare.”

Read it all here.